Main Business

Stella Pharma is working on the development of drugs for BNCT (Boron Neutron Capture Therapy). This development was selected as the FY2008 outsourced development project for the Japan Science and Technology Agency (JST).

We were a cooperating company in the “Project for the Creation of Innovative Medical Devices Pioneered by Imaging Technology: From Ultra-early Diagnosis to Cutting-Edge Treatment,” which has been adopted as a special zone for advanced medical device development (super special zone), a science and technology policy of the Cabinet Office, Government of Japan.